TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.

E Massarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.